Dr. Joseph Geraci is a mathematician, medical scientist, and AI algorithm developer. He holds three postdocs in oncology, AI for medicine, and biological psychiatry. He has 15 years of experience developing machine intelligence applications in medicine including for biomarker development, drug discovery, patient stratification, and clinical trial decision support augmentation. He is affiliated with Augusta University in Georgia, USA, Queen’s University in Kingston, Ontario, and the University of California, San Diego.

Dr. Geraci is the founder of NetraMark which is a company in Toronto, Ontario that has built a unique AI platform for decision augmentation for clinical trials where they service several pharmaceutical companies as they progress through their clinical programs. He is currently the Chief Technology Officer and Chief Scientific Officer at NetraMark and president at an AI consulting firm.